19 April 2023
AMA Group (AMA): Still needs work
AMA downgraded its FY23 normalised EBITDA guidance from $70-90m to $60-68m (vs BP forecast $71m) and cited “ongoing margin compression” as the key reason which was driven by labour constraints, higher employee costs and many contracts not containing appropriate adjustment mechanisms from inflation and/or repair severity.
6 April 2023
End of Quarter Review – March 2023
The March 2023 quarter started with investor confidence riding high through January amid expectations inflation had peaked and central banks would avoid a hard economic landing.
22 March 2023
Synlait Milk Ltd (SM1): Rabbit don’t come easy
SM1 have downwardly revised FY23e NPAT expectations relative to market expectations ahead of its 1H23e result. We have downgraded our target price to A$3.20ps (prev. A$4.00ps).
7 March 2023
GenusPlus Group Ltd (GNP): Power to the people
We have transferred GNP analyst coverage and maintain our Buy recommendation with a Target Price of $1.18/sh (previously $1.72/sh).